Search Results - "Elisei, W"

Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease – a double‐blind, randomised, placebo‐controlled study by Tursi, A., Brandimarte, G., Elisei, W., Picchio, M., Forti, G., Pianese, G., Rodino, S., D'Amico, T., Sacca, N., Portincasa, P., Capezzuto, E., Lattanzio, R., Spadaccini, A., Fiorella, S., Polimeni, F., Polimeni, N., Stoppino, V., Stoppino, G., Giorgetti, G. M., Aiello, F., Danese, S.

“…Summary Background Placebo‐controlled studies in maintaining remission of symptomatic uncomplicated diverticular disease (SUDD) of the colon are lacking. Aim…”
Get full text

Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease by Tursi, A., Elisei, W., Giorgetti, G. M., Aiello, F., Brandimarte, G.

“…Aliment Pharmacol Ther 2011; 33: 358–365 Summary Background  Ulcerative colitis with diverticulosis (UCD), segmental colitis associated with diverticulosis…”
Get full text

Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn’s disease: an open-label, pilot study by Tursi, A., Elisei, W., Picchio, M., Zampaletta, C., Pelecca, G., Faggiani, R., Brandimarte, G.

“…Background Endoscopic and clinical recurrence of Crohn’s disease (CD) appears in up to 80 and 30 % of patients, respectively, 1 year after surgery. Both…”
Get full text

Impact of treatments on fecal microbiota and fecal metabolome in symptomatic uncomplicated diverticular disease of the colon: a pilot study by Laghi, L, Mastromarino, P, Elisei, W, Capobianco, D, Zhu, C L, Picchio, M, Giorgetti, G, Brandimarte, G, Tursi, A

“…Symptomatic uncomplicated diverticular disease (SUDD) affects 50% of people having diverticulosis. We performed a pilot study assessing the effect of current…”
Get more information

Musosal tumour necrosis factor α in diverticular disease of the colon is overexpressed with disease severity by Tursi, A., Elisei, W., Brandimarte, G., Giorgetti, G. M., Inchingolo, C. D., Nenna, R., Picchio, M., Giorgio, F., Ierardi, E.

“…Aim  Inflammation occurs in diverticular disease (DD), but there is little information on inflammatory cytokines such as tumour necrosis factor α (TNF‐α). The…”
Get full text

Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study by Tursi, A, Mocci, G, Cuomo, A, Allegretta, L, Aragona, G, Colucci, R, Della Valle, N, Ferronato, A, Forti, G, Gaiani, F, Graziani, M G, Lorenzetti, R, Luzza, F, Paese, P, Penna, A, Pica, R, Piergallini, S, Pranzo, G, Rodino, S, Scarcelli, A, Zampaletta, C, Cicerone, C, Cocco, A, De' Angelis, G, Donnarumma, L, Franceschi, M, Gallina, S, Grasso, G, Larussa, T, Luppino, I, Faggiani, R, Fanigliulo, L, Pagnini, C, Perazzo, P, Sacco, R, Sebkova, L, Scorza, S, Serio, M, De Monti, A, Picchio, M, Elisei, W, Maconi, G

“…Ustekinumab (UST) is an anti-IL12/23 antibody for the treatment of Crohn's Disease (CD). The aim of this study was to compare the efficacy and safety of UST in…”
Get more information

Letter: are infliximab and adalimumab similar for Crohn's disease in clinical practice? by Tursi, A., Elisei, W., Picchio, M., Penna, A.

Get full text

Decreasing efficacy of the standard seven-day triple therapy containing amoxycillin and clarithromycin in curing Helicobacter pylori infection in clinical setting in Italy: a 10-year follow-up study by Tursi, A, Elisei, W, Giorgetti, G, Picchio, M, Brandimarte, G

“…The aim of the present study was to assess the efficacy of the standard triple therapy containing PPI plus amoxycillin and clarithromycin in curing…”
Get more information

The endoscopic spectrum of segmental colitis associated with diverticulosis by Tursi, A., Elisei, W., Brandimarte, G., Giorgetti, G. M., Lecca, P. G., Di Cesare, L., Inchingolo, C. D., Aiello, F.

“…Objective  An endoscopic classification of ‘Segmental colitis associated with diverticulosis’ (SCAD) is lacking. Our aim was therefore to assess the endoscopic…”
Get full text

Mesalazine and/or Lactobacillus casei in Preventing Recurrence of Symptomatic Uncomplicated Diverticular Disease of the Colon: A Prospective, Randomized, Open-label Study by Tursi, Antonio, Brandimarte, Giovanni, Giorgetti, Gian Marco, Elisei, Walter

“…GOALSTo investigate the effectiveness and safety of mesalazine, with or without Lactobacillus casei, in preventing recurrence of symptomatic diverticular…”
Get full text

Letter: infliximab vs. adalimumab in treating ambulatory perianal fistulising Crohn's disease by Tursi, A., Elisei, W., Picchio, M., Zampaletta, C., Faggiani, R., Brandimarte, G.

Get full text

Letter: diverticulosis in inflammatory bowel diseases by Tursi, A., Elisei, W., Picchio, M., Forti, G., Giorgetti, G., Faggiani, R., Zampaletta, C., Brandimarte, G.

Get full text

V.02.6 SCISSOR-SHAPED SB KNIFE WITH THE DIVERTICULOSCOPE ASSISTANCE FOR ZENKER DIVERTICULUM SEPTOTOMY by Iacopini, F, Costamagna, G, Elisei, W, Scozzarro, A

Get full text

P.07.7: Impact of Endoscopic Classification “Dica” on the Burden of Diverticular Disease of the Colon in Italy by Brandimarte, G, Nasi, G, Mastromatteo, A, Elisei, W, Picchio, M, Di Mario, F, Tursi, A

Get full text

P.12.11: Endoscopic Submucosal Dissection (ESD) of Superficial Colorectal Neoplasms at the Anal Canal and Ileocecal Valve by Iacopini, F, Saito, Y, Gotoda, T, Elisei, W, Grossi, C, Montagnese, F, Andrei, F, Costamagna, G

Get full text

OC.12.3: Difficulty Levels of Colorectal Endoscopic Submucosal Dissection (ESD): Preoperative and Intraoperative Prognostic Indicators in the Western Setting by Iacopini, F, Saito, Y, Bella, A, Gotoda, T, Rigato, P, Elisei, W, Montagnese, F, Grossi, C, Costamagna, G

Get full text

Mucosal expression of basic fibroblastic growth factor, Syndecan 1 and tumor necrosis factor-alpha in diverticular disease of the colon: a case-control study by Tursi, A., Elisei, W., Brandimarte, G., Giorgetti, G. M., Inchingolo, C. D., Nenna, R., Picchio, M., Giorgio, F., Ierardi, E.

“…Background  Inflammation may be detected in diverticular disease (DD), and fibrosis may also develop. We assessed the mucosal expression of bFGF, SD1, and…”
Get full text

Expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor α in resected acute colonic diverticulitis by Tursi, A., Elisei, W., Giorgetti, G. M., Inchingolo, C. D., Nenna, R., Picchio, M., Giorgio, F., Ierardi, E., Brandimarte, G.

“…Aim Inflammation and fibrosis are present in both colonic diverticulitis and Crohn's disease (CD). The molecular pattern of basic fibroblastic growth factor…”
Get full text

OC.01.5 ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) OF LARGE SUPERFICIAL COLORECTAL NEOPLASMS AT THE DENTATE LINE OR ILEOCECAL VALVE by Iacopini, F, Elisei, W, Grossi, C, Montagnese, F, Andrei, F, Gotoda, T, Saito, Y, Costamagna, G

Get full text

OC.10.8 PREDICTION OF TECHNICAL DIFFICULTY OF COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD): PROSPECTIVE STUDY TO FAVOR ITS PRACTICE IN THE WEST by Iacopini, F, Grossi, C, Elisei, W, Montagnese, F, Saito, Y, Andrei, F, Gotoda, T, Rigato, P, Costamagna, G

Get full text